Science Recorder
FDA Approves New Type 2 Diabetes Drug
WebMD
TUESDAY, April 15, 2014 (HealthDay News) — Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum. The FDA described Tanzeum …
FDA approves Tanzeum to treat type 2 diabetesFox News
GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum Wall Street Journal
GlaxoSmithKline wins an FDA nod for its GLP-1 diabetes drug albiglutideFierceBiotech
Kansas City Star -The News Journal
all 85 news articles »

diabetes – Google News


Economic Times
Lexicon Pharma's diabetes drug successful in mid-stage study
Yahoo News
(Reuters) – Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes reduced the use of insulin at meal times in a mid-stage study of patients with type 1 diabetes, sending the company's shares up as much as 17 percent. Lexicon said the
Lexicon's Type 1 Diabetes Trial Gets Positive ResultsDrug Discovery & Development

all 24 news articles »

diabetes – Google News

$ 6 Billion Jury Award Over Diabetes Drug
ABC News (blog)
Takeda Pharmaceuticals, Japan's biggest drug-maker, has been hit with $ 6 billion in punitive damages for hiding a possible link between a best-selling diabetes drug and a patient's bladder cancer. The fight is over Actos. Eli Lilly, which marketed the

and more »

diabetes – Google News


Legal Examiner
Takeda Loses First Federal Trial Over Actos Diabetes Drug
Bloomberg
Takeda, Asia's largest drugmaker, faces the Actos claims after it scrapped development of another diabetes drug this year when research linked it to liver damage. More than 2,700 Actos suits have been consolidated before U.S. District Judge Rebecca …
Takeda Jury Told of 'Reckless' Handling of Diabetes Drug (1)Businessweek
Billion-Dollar Lawsuit Against Actos Resumes TodayDrugWatch.com
Actos Bellwether Trial: $ 9 Billion Verdict for PlaintiffsLegal Examiner

all 9 news articles »

diabetes – Google News


CNBC.com
FDA advisers back MannKind's inhaled diabetes drug
CNBC.com
U.S. health advisers on Tuesday recommended approval of MannKind's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with traditional insulin therapy. Shares of Mannkind …
FDA Panel Backs Inhaled, Injection-Free Diabetes DrugHuffington Post
US FDA advisers back MannKind's inhaled diabetes drugReuters
MannKind shares soar on FDA panel's support of diabetes drugLos Angeles Times
Refinery29 -Drug Discovery & Development
all 155 news articles »

diabetes – Google News


Guardian Liberty Voice
US FDA advisers back MannKind's inhaled diabetes drug
Reuters
HYATTSVILLE, Maryland (Reuters) – U.S. health advisers on Tuesday recommended approval of MannKind Corp's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with …
FDA panel backs MannKind Corp.'s diabetes drug AfrezzaLos Angeles Times
Mannkind (MNKD) Confirms FDA Panel Backs AFREZZA for DiabetesStreetInsider.com (subscription)
U.S. FDA advisers recommend Mannkind's inhaled diabetes drug AfrezzaGlobalPost

all 68 news articles »

diabetes – Google News


Nature World News
FDA spurns Lilly, Boehringer diabetes drug, cites factory problems
Reuters
(Reuters) – Eli Lilly and Co and partner Boehringer Ingelheim said U.S. regulators have declined to approve their experimental diabetes drug empagliflozin, citing previously observed problems at a facility where it would be made. The drugmakers, in a
FDA rejects Eli Lilly's SGLT2 diabetes drug empagliflozinFierceBiotech
FDA re-evaluating manufacturing process of diabetes pill as it considers Washington Post
FDA Nixes Diabetes Drug Citing Manufacturing IssuesMedPage Today
Nature World News
all 76 news articles »

diabetes – Google News


Nature World News
FDA Nixes Diabetes Drug Citing Manufacturing Issues
MedPage Today
The investigational type 2 diabetes drug empagliflozin won't win the FDA's approval until "previously observed deficiencies" at a manufacturing plant are fixed, the drug's sponsors said Wednesday. Eli Lilly and its partner Boehringer Ingelheim said the
FDA re-evaluating manufacturing process of diabetes pill as it considers Washington Post
Eli Lilly's Diabetes Drug Approval Halted by FDA over Facility Quality IssuesNature World News
FDA spurns Lilly, Boehringer diabetes drug, cites factory problemsReuters
FierceBiotech -Tech Times
all 66 news articles »

diabetes – Google News


Medical Marketing and Media
Lilly weekly diabetes drug as effective as market leader Victoza-study
Reuters
(Reuters) – An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co proved as effective in lowering blood sugar as Victoza from Danish drugmaker Novo Nordisk in an eagerly anticipated late stage study. The Lilly drug 
Lilly Diabetes Drug Ruled Comparable to Market LeaderWall Street Journal
Lilly diabetes drug meets late-stage goalWISH
Results of experimental diabetes drug encouraging for Eli Lilly and Co.Indianapolis Star

all 44 news articles »

diabetes – Google News

FDA to investigate diabetes drug
WZZM
FDA to investigate diabetes drug. The Food and Drug Administration will investigate a link between a relatively new diabetes drug and a higher risk for heart failure. Loading… Post to Facebook. FDA to investigate diabetes drug on WZZM13.com: 
FDA to review safety of AZ's saxagliptinPMLiVE

all 2 news articles »

diabetes – Google News